Karolina Haber1, Alexandra Neagu2, Wiesław Konopka3, Katarzyna Amernik4, Dan Cristian Gheorghe2,5, Maria Drela6, Iwona Wrukowska-Niemczewska6, Józef Mierzwiński6,7. 1. Department of Otolaryngology, Audiology and Phoniatrics, Pediatric Cochlear Implant Program, Children's Hospital of Bydgoszcz, Ul. Chodkiewicza 44, 85-667, Bydgoszcz, Poland. karolina.haber.757@gmail.com. 2. ENT Clinic, Paediatric Emergency Hospital M.S. Curie, Bucharest, Romania. 3. Department of Otolaryngology, Polish Mother's Memorial Hospital, ul. Rzgowska 281/289, 93-338, Łódź, Poland. 4. Autonomous Public Clinical Hospital No. 1 of Pomeranian Medical University, ul. Unii Lubelskiej 1, 71-242, Szczecin, Poland. 5. Department of Otorhinolaryngology, Carol Davila University, Bucharest, Romania. 6. Department of Otolaryngology, Audiology and Phoniatrics, Pediatric Cochlear Implant Program, Children's Hospital of Bydgoszcz, Ul. Chodkiewicza 44, 85-667, Bydgoszcz, Poland. 7. Department of Preventive Nursing, Nicolaus Copernicus University, Collegium Medicum, Łukasiewicza 1, 85-821, Bydgoszcz, Poland.
Abstract
PURPOSE: Hearing preservation cochlear implantation is an established procedure in patients with low-frequency residual hearing, especially in pediatric cochlear implantation. More delicate, thin electrode arrays can minimize damage in the inner ear and enhance the possibility for residual hearing preservation. The Cochlear® CI532 electrode has been reported as an electrode with the potential for residual hearing preservation. No similar studies pertaining to hearing preservation in pediatric patients have appeared to date. The aim of this study was to investigate whether the Cochlear® CI532 Slim Modiolar electrode allows the preservation of low-frequency residual hearing in children undergoing cochlear implantation. METHODS: In this multicenter, nonrandomized, prospective clinical cohort study, medical data of 14 pediatric patients implanted with the CI532 were collected. All patients had residual low-frequency hearing (preoperative audiogram or ABR with at least one threshold better than 90 dB HL at 125, 250, 500, or 1000 Hz). Postoperative thresholds were obtained 1, 3, 6, and 12 months after cochlear implantation. RESULTS: Based on the HEARRING classification, 78.6% of children (11/14) had complete hearing preservation at the last follow-up visit (12 months after CI, or if not available, 6 months). A total of 21.4% (3/14) had partial hearing preservation. At the last follow-up visit, neither minimal hearing preservation nor loss of hearing was observed. Functional low-frequency hearing was preserved in 13 out of 14 patients (93%). CONCLUSIONS: The residual hearing preservation results in children were superior to the results previously reported in adults.
PURPOSE: Hearing preservation cochlear implantation is an established procedure in patients with low-frequency residual hearing, especially in pediatric cochlear implantation. More delicate, thin electrode arrays can minimize damage in the inner ear and enhance the possibility for residual hearing preservation. The Cochlear® CI532 electrode has been reported as an electrode with the potential for residual hearing preservation. No similar studies pertaining to hearing preservation in pediatric patients have appeared to date. The aim of this study was to investigate whether the Cochlear® CI532 Slim Modiolar electrode allows the preservation of low-frequency residual hearing in children undergoing cochlear implantation. METHODS: In this multicenter, nonrandomized, prospective clinical cohort study, medical data of 14 pediatric patients implanted with the CI532 were collected. All patients had residual low-frequency hearing (preoperative audiogram or ABR with at least one threshold better than 90 dB HL at 125, 250, 500, or 1000 Hz). Postoperative thresholds were obtained 1, 3, 6, and 12 months after cochlear implantation. RESULTS: Based on the HEARRING classification, 78.6% of children (11/14) had complete hearing preservation at the last follow-up visit (12 months after CI, or if not available, 6 months). A total of 21.4% (3/14) had partial hearing preservation. At the last follow-up visit, neither minimal hearing preservation nor loss of hearing was observed. Functional low-frequency hearing was preserved in 13 out of 14 patients (93%). CONCLUSIONS: The residual hearing preservation results in children were superior to the results previously reported in adults.
Authors: Jan Kiefer; Wolfgang Gstoettner; Wolfgang Baumgartner; Stephan Marcel Pok; Jochen Tillein; Qing Ye; Christoph von Ilberg Journal: Acta Otolaryngol Date: 2004-04 Impact factor: 1.494
Authors: Sarah Havenith; Marc J W Lammers; Rinze A Tange; Franco Trabalzini; Antonio della Volpe; Geert J M G van der Heijden; Wilko Grolman Journal: Otol Neurotol Date: 2013-06 Impact factor: 2.311
Authors: Peter Luke Santa Maria; Michael Brian Gluth; Yongqing Yuan; Marcus David Atlas; Nikolas H Blevins Journal: Otol Neurotol Date: 2014-12 Impact factor: 2.311
Authors: René H Gifford; Michael F Dorman; Henryk Skarzynski; Artur Lorens; Marek Polak; Colin L W Driscoll; Peter Roland; Craig A Buchman Journal: Ear Hear Date: 2013 Jul-Aug Impact factor: 3.570
Authors: Gunesh Rajan; Dayse Tavora-Vieira; Wolf-Dieter Baumgartner; Benoit Godey; Joachim Müller; Martin O'Driscoll; Henryk Skarzynski; Piotr Skarzynski; Shin-Ichi Usami; Oliver Adunka; Sumit Agrawal; Iain Bruce; Marc De Bodt; Marco Caversaccio; Harold Pilsbury; Javier Gavilán; Rudolf Hagen; Abdulrahman Hagr; Mohan Kameswaran; Eva Karltorp; Martin Kompis; Vlad Kuzovkov; Luis Lassaletta; Li Yongxin; Artur Lorens; Manikoth Manoj; Jane Martin; Griet Mertens; Robert Mlynski; Lorne Parnes; Sasidharan Pulibalathingal; Andreas Radeloff; Christopher H Raine; Ranjith Rajeswaran; Joachim Schmutzhard; Georg Sprinzl; Hinrich Staecker; Kurt Stephan; Serafima Sugarova; Mario Zernotti; Patrick Zorowka; Paul Van de Heyning Journal: Cochlear Implants Int Date: 2017-10-26